Association between loss of hypercoagulable phenotype, clinical features and complement pathway consumption in COVID-19
BackgroundCoronavirus disease 2019 (COVID-19) features a hypercoagulable state, but therapeutic anticoagulation effectiveness varies with disease severity. We aimed to evaluate the dynamics of the coagulation profile and its association with COVID-19 s…